tykhr
sign in
free sign up
Pieris Pharmaceuticals Inc
Biotechnology
Healthcare
PIRS
74.40 M shares
NASDAQ US
traded
16 Mar 2023
listed
yes
open
1.43
52 week high
4.52
high
1.45
52 week low
1.33
low
1.37
growth
-54.28 %
previous Close
1.46
P/E ratio
market cap
101 M
div yield
0
usd
Sep 2022
qoq
revenue
5.37 M
45.21 %
net incoming
-9.74 M
5.82 %
eps
0.00 %
7.14 %
eps surprise
18.75 %
net profit margin
-181.30 %
98.00 %
operating incoming
-12.17 M
1.31 %
net change in cash
-5.83 M
80.21 %
cash on hand
48.42 M
-10.75 %
cost of revenue
0.00 %
top